Frankfurt
03.10.25 | 08:06
0,049 Euro
+1,04 % +0,001
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,058 | 0,064 | 04.10. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Ventripoint Diagnostics Ltd (2): Ventripoint to extend, increase debenture financing | 2 | Stockwatch | ||
| Fr | Ventripoint Diagnostics Ltd.: Ventripoint Announces Extension and Up Size of Non-Brokered Convertible Debenture Unit Private Placement | 2 | TheNewswire | ||
| 19.09. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics completes annual quality audit | 1 | Stockwatch | ||
| 19.09. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Successful Completion of Key Quality Audits | 2 | TheNewswire | ||
| 03.09. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Unit Private Placement | 1 | TheNewswire | ||
| 27.08. | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $5M financing of debenture units | 1 | Stockwatch | ||
| 26.08. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement and Share Issuance | 2 | TheNewswire | ||
| 19.08. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Brown as program director | 1 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 18.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program | 1 | TheNewswire | ||
| 15.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Launches Targeted Congenital Heart Defect Marketing Program, Setting Stage for Multi-Segment Growth | 1 | TheNewswire | ||
| 13.08. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans | 315 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining... ► Artikel lesen | |
| 29.07. | Ventripoint Diagnostics Ltd (2): Ventripoint receives purchase order from Lishman | 1 | Stockwatch | ||
| 28.07. | Ventripoint Diagnostics Ltd.: Lishman Global Places First Order for Ventripoint's VMS+ Technology | 1 | TheNewswire | ||
| 11.07. | Ventripoint Diagnostics Ltd (2): Ventripoint enters term sheet with Lishman for licence | 1 | Stockwatch | ||
| 11.07. | Ventripoint Diagnostics Ltd.: Ventripoint and Lishman Global Sign Non-binding Term Sheet Defining License for VMS+ Technology | 2 | TheNewswire | ||
| 11.07. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 564,473 shares for debt | 1 | Stockwatch | ||
| 30.06. | Ventripoint Diagnostics Ltd (2): Ventripoint to settle debenture interest with shares | 2 | Stockwatch | ||
| 30.06. | Ventripoint Diagnostics Ltd.: Ventripoint to Issue Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 18.06. | Ventripoint Diagnostics Ltd (2): Ventripoint hires Fournel for advisory services | 1 | Stockwatch | ||
| 17.06. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics grants options | 4 | Stockwatch |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,850 | +0,71 % | Atossa Therapeutics appoints Janet Rea as SVP of R&D | ||
| TANDEM DIABETES | 11,125 | +6,00 % | Tandem Diabetes: Insulinpumpe erhält US-Zulassung für ultraschnelles Insulin von Lilly | ||
| VERU | 3,790 | -1,81 % | These small cap stocks are poised for a comeback - Palisade Capital's Dan Veru | ||
| MOLINA HEALTHCARE | 171,95 | +0,47 % | Molina Healthcare Board Member Makes $54K Stock Purchase | ||
| CLOVER HEALTH INVESTMENTS | 2,234 | +1,41 % | TotalEnergies SE - Angola: Start-up of BEGONIA and CLOV Phase 3 Offshore Projects | TotalEnergies announces the start of production from the BEGONIA and CLOV Phase 3 projects, adding a total of 60,000 barrels per day of production offshore Angola. Low cost, low emissions... ► Artikel lesen | |
| COGNETIVITY NEUROSCIENCES | 0,015 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
| SEMLER SCIENTIFIC | 25,600 | -1,54 % | Semler Scientific, Inc. - 8-K, Current Report | ||
| SOMNIGROUP INTERNATIONAL | 71,50 | -0,69 % | SOMNIGROUP INTERNATIONAL INC. - 8-K, Current Report | ||
| SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer | ||
| SINTX TECHNOLOGIES | 3,960 | -3,41 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| SMILEDIRECTCLUB | - | - | Align Technology Settles Antitrust Lawsuit Over SmileDirectClub Deal for $31.75 Million | ||
| NEURONETICS | 2,450 | +1,66 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,640 | +1,56 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,160 | +0,32 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 28,360 | -1,36 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,049 Euro und damit +1,04 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.